Revance Therapeutics Inc(RVNC)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RVNC Revance Therapeutics Inc

交易中 08-16 13:08:18 EDT

6.62

+0.03

+0.38%

最高6.63	最低6.58	成交量669.91万
今开6.59	昨收6.59	日振幅0.83%
总市值6.93亿	流通市值5.56亿	总股本1.05亿
成交额4,418万	换手率7.97%	流通股本8,403万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RVNC","market":"US","secType":"STK","nameCN":"Revance Therapeutics Inc","latestPrice":6.615,"timestamp":1723828095430,"preClose":6.59,"halted":0,"volume":6699117,"delay":0,"floatShares":84031602,"shares":104823331,"eps":-3.113876,"marketStatus":"交易中","marketStatusCode":2,"change":0.025,"latestTime":"08-16 13:08:18 EDT","open":6.59,"high":6.63,"low":6.575,"amount":44180505.787516505,"amplitude":0.008346,"askPrice":6.62,"askSize":23060,"bidPrice":6.61,"bidSize":9395,"shortable":3,"etf":0,"ttmEps":-3.113876,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1723838400000},"adr":0,"listingDate":1391662800000,"adjPreClose":6.59,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":6.58,"preClose":6.59,"latestTime":"09:25 EDT","volume":7781,"amount":51199.182306,"timestamp":1723814730039},"postHourTrading":{"tag":"盘后","latestPrice":6.58,"preClose":6.59,"latestTime":"19:29 EDT","volume":289086,"amount":1905065.6397,"timestamp":1723764552710},"volumeRatio":0.616882,"impliedVol":0.2645,"impliedVolPercentile":0.004},"requestUrl":"/m/hq/s/RVNC/tweets","defaultTab":"tweets","newsList":[{"id":"2459937738","title":"BUZZ--美国股票走势-Revance, B Riley, Neuronetics","url":"https://stock-news.laohu8.com/highlight/detail?id=2459937738","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459937738?lang=zh_cn&edition=full","pubTime":"2024-08-13 02:26","pubTimestamp":1723487209,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      8月12日 - 美国股市周一在寻找方向的过程中陷入困境，投资者正在为本周的一系列经济数据做准备，他们重点关注美国消费者物价，以衡量美联储货币政策路径的前景。美东时间13:44，道琼斯工业平均指数  为!标普500指数  上涨0.01%，报5344.68点；纳斯达克综合指数  上涨0.35%，报16803.296点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVNC","TJX",".DJI","LU2505996681.GBP","MNQmain","LU0820561909.HKD","LU0175139822.USD","LU1861558580.USD","QID","HPE","TQQQ","HE","IE0009355771.USD","NVDA",".SPX","RILY","LU2756315318.SGD","LU0097036916.USD","SMCI","LU2505996509.AUD","SQQQ","NQmain","DLTR","ULCC","DXD","PSQ","SDOW","HUMA","KEY","LU0689472784.USD","COHR","IBM",".IXIC","DG","LU0096364046.USD","HD","QLD","BUZZ","WVE","DDM","DOG","JBLU","UDOW","DJX","STIM"],"gpt_icon":1},{"id":"2459377339","title":"BUZZ--美国股票走势-Revance, B Riley, Neuronetics","url":"https://stock-news.laohu8.com/highlight/detail?id=2459377339","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459377339?lang=zh_cn&edition=full","pubTime":"2024-08-13 02:26","pubTimestamp":1723487209,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      8月12日 - 美国股市周一在寻找方向的过程中陷入困境，投资者正在为本周的一系列经济数据做准备，他们重点关注美国消费者物价，以衡量美联储货币政策路径的前景。美东时间13:44，道琼斯工业平均指数  为!标普500指数  上涨0.01%，报5344.68点；纳斯达克综合指数  上涨0.35%，报16803.296点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NQmain","DOG","HUMA","QID","HPE","LU2505996681.GBP","DLTR","KEY","HD","SBUX","TJX","TQQQ","LU0689472784.USD",".SPX","SQQQ","LU0820561909.HKD","STIM","MNQmain","QLD","COHR","HE","DXD",".IXIC","DJX","LU2756315318.SGD","RILY",".DJI","CLSK","IE0009355771.USD","HOOD","DG","LUMN","JBLU","ULCC","DDM","LU1861558580.USD","PSQ","IBM","LU0175139822.USD","LU0096364046.USD","LU0097036916.USD","LLY","WVE","RVNC","LU2505996509.AUD","SDOW","UDOW","BUZZ"],"gpt_icon":1},{"id":"2458498510","title":"今日优惠-合并与收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2458498510","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458498510?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:38","pubTimestamp":1723469928,"startTime":"0","endTime":"0","summary":"     路透8月12日 - 截至格林尼治标准时间周一 1330 时，有以下竞购、兼并、收购和处置报告：    ** 抗皱注射剂生产商Revance Therapeutics   已同意被私人控股的Crown Laboratories收购，交易价值9.24亿美元，包括债务在内。** 英国竞争监督机构表示，它正在调查芯片设计软件制造商Synopsys  斥资350亿美元收购Ansys  是否会影响英国的竞争。** 英国皇家邮政母公司国际配送服务公司  宣布，其包裹服务业务GLS将把美国货运部门出售给总部位于加利福尼亚州的DC物流公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","RVNC","BK4585","LU0053671581.USD","BK4007"],"gpt_icon":0},{"id":"2458985111","title":"Revance Therapeutics, Inc.盘中异动 股价大涨85.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458985111","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458985111?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:31","pubTimestamp":1723469484,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时31分，Revance Therapeutics, Inc.股票出现波动，股价快速拉升85.55%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。消息层面，截至21时31分，Revance Therapeutics, Inc.股票正面舆情新闻比例33.33%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122131249f248f7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122131249f248f7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4588","BK4007","LU0053671581.USD","RVNC","BK4585"],"gpt_icon":0},{"id":"2458298322","title":"BUZZ--美国股票走势-Revance Therapeutics、B Riley Financial、KeyCorp","url":"https://stock-news.laohu8.com/highlight/detail?id=2458298322","media":"Reuters","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458298322?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:27","pubTimestamp":1723469245,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      8月12日 - 华尔街周一将高开高走，股指将从上周初的重挫中回升，投资者将为包括美国消费者价格在内的大量数据做好准备。美东时间9:06，道指电子盘  上涨0.12%，报39,688 点。标普500指数小型股  上涨0.21%，报5,381.5点；纳斯达克100指数小型股  上涨0.25%，报18,661.75点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640476718.USD","LU1035773651.USD","RILY","BK4504","LU0417517546.SGD","BK4592","BK4581","LU1430594728.SGD","BK4534","LU2125154935.USD","BUZZ","BK4211","LU0823417653.USD","IE00B894F039.SGD","LU0053671581.USD","LU0289960550.SGD","IE0031619046.USD","BK4081","LU1585245621.USD","KEY","LU2506951958.HKD","BK4139","LU2092937221.SGD","IE00B19Z9Z06.USD","LU1064131342.USD","LENZ","HE","LU2125154778.USD","LU1814569148.SGD","BK4532","BK4159","LU2360032135.SGD","BK4589","DLTR","RVNC","TJX","GNLN","HUMA","LU2506952170.USD","BK4155","LU1988902786.USD","JBLU","BK4588","LU0094547139.USD","BK4127","LU2506952097.USD","LU2133065610.SGD","BK4500"],"gpt_icon":1},{"id":"2458764607","title":"BUZZ-Revance 因被 Crown Laboratories 以 9.24 亿美元收购而大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2458764607","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458764607?lang=zh_cn&edition=full","pubTime":"2024-08-12 20:39","pubTimestamp":1723466349,"startTime":"0","endTime":"0","summary":"    8月12日 - ** 抗皱注射剂生产商Revance Therapeutics   股价盘前上涨84.7%，至6.52美元** RVNC称，  私人护肤品公司Crown Laboratories将收购RVNC，包括债务在内的私有化交易价值为9.24亿美元。** Crown将以每股6.66美元的现金收购RVNC股票，较该股最后收盘价溢价约89%。** 交易预计在年底前完成** Revance 公司生产的 Daxxify 是艾伯维公司    广受欢迎的抗皱注射剂肉毒杆菌毒素的竞争对手。** 截至上一交易日收盘，RVNC股价年累计下跌约60","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVNC","BK4585","LU0053671581.USD","BK4588","BUZZ","BK4007"],"gpt_icon":0},{"id":"2458604477","title":"抗皱注射剂生产商 Revance 将通过 9.24 亿美元的交易实现私有化","url":"https://stock-news.laohu8.com/highlight/detail?id=2458604477","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458604477?lang=zh_cn&edition=full","pubTime":"2024-08-12 20:07","pubTimestamp":1723464468,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透8月12日 - 抗皱注射剂生产商Revance Therapeutics   和私人护肤品公司Crown Laboratories周一表示，两家公司将以私有化的方式收购Revance Therapeutics   ，包括债务在内的交易价值为9.24亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","BK4588","RVNC","BK4007","BK4585"],"gpt_icon":0},{"id":"2458515563","title":"BUZZ-Revance Therapeutics 美容产品第二季度销售额增加，业绩增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2458515563","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458515563?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:14","pubTimestamp":1723220040,"startTime":"0","endTime":"0","summary":"    8月9日 - ** 美容药品制造商 Revance Therapeutics    股价上涨约 21%，报 3.55 美元** 该公司是纳斯达克生物技术指数  中涨幅最大的公司之一 ** 周四晚些时候，Revance公布第二季度产品净收入为6540万美元，去年同期为5440万美元。** RVNC 的产品收入包括抗皱注射剂 Daxxify 和面部填充剂 RHA Collection 的销售收入。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK0235","BK4585","002798","RVNC","LU0053671581.USD","BK4007"],"gpt_icon":0},{"id":"2458595423","title":"Revance Therapeutics, Inc.盘中异动 急速上涨11.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458595423","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458595423?lang=zh_cn&edition=full","pubTime":"2024-08-09 21:31","pubTimestamp":1723210295,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日21时31分，Revance Therapeutics, Inc.股票出现波动，股价快速拉升11.86%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Third Harmonic Bio, Inc.、Adma Biologics Inc涨幅较大，Conduit Pharmaceuticals Inc.、Cns Pharmaceuticals, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为32.77%、5.41%、4.90%，振幅较大的相关个股有Brainstorm Cell Therapeutics Inc.、Enliven Therapeutics, Inc.、Relmada Therapeutics, Inc.，振幅分别为10.21%、9.58%、9.57%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408092131369f1dc151&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408092131369f1dc151&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LU0053671581.USD","BK4007","BK4588","BK4139","RVNC","BK4585"],"gpt_icon":0},{"id":"2457873406","title":"Revance Therapeutics, Inc.盘中异动 股价大跌5.19%报2.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457873406","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457873406?lang=zh_cn&edition=full","pubTime":"2024-08-08 02:35","pubTimestamp":1723055713,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日02时35分，Revance Therapeutics, Inc.股票出现波动，股价快速下跌5.19%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.59%。其相关个股中，G1 Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Salarius Pharmaceuticals, Inc.涨幅较大，Aditxt, Inc.、Salarius Pharmaceuticals, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为5153.88%、2606.04%、326.10%，振幅较大的相关个股有Aditxt, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Salarius Pharmaceuticals, Inc.，振幅分别为101.30%、69.66%、62.37%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808023513aefdbecd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808023513aefdbecd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","RVNC","BK4139","BK4585","BK4007","LENZ","BK4588"],"gpt_icon":0},{"id":"2457776656","title":"Revance Therapeutics, Inc.股价重挫12.66% 市值跌3695.88万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457776656","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457776656?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:42","pubTimestamp":1722865341,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时42分，Revance Therapeutics, Inc.股票出现波动，股价大幅下跌12.66%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.13%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Zevra Therapeutics, Inc.、Cervomed Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为1101.40%、54.51%、14.22%，振幅较大的相关个股有Anew Medical Inc C/Wts 21/06/2029 、Alpha Tau Medical Ltd C/Wts 、Cns Pharmaceuticals, Inc.，振幅分别为27.34%、26.68%、21.59%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805214221957f34d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805214221957f34d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","RVNC","BK4139","LU0053671581.USD","BK4588","LENZ","BK4007"],"gpt_icon":0},{"id":"2456728112","title":"Revance Therapeutics, Inc.盘中异动 大幅跳水5.34%报3.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456728112","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456728112?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:36","pubTimestamp":1722605769,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时36分，Revance Therapeutics, Inc.股票出现波动，股价急速下挫5.34%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Exicure, Inc.、Os Therapies Incorporated、Dermata Therapeutics, Inc.涨幅较大，Exicure, Inc.、Dermata Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为396.36%、229.63%、22.31%，振幅较大的相关个股有Exicure, Inc.、Dermata Therapeutics, Inc.、Os Therapies Incorporated，振幅分别为33.34%、31.45%、22.31%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408022136109682341f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408022136109682341f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4585","RVNC","BK4588","BK4139","LU0053671581.USD"],"gpt_icon":0},{"id":"2456433096","title":"Revance Therapeutics, Inc.盘中异动 股价大跌5.03%报3.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456433096","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456433096?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:54","pubTimestamp":1722520460,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日21时54分，Revance Therapeutics, Inc.股票出现波动，股价大幅下跌5.03%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Immuneering Corporation、Biomea Fusion, Inc.、Genenta Science Spa涨幅较大，Immuneering Corporation、Cns Pharmaceuticals, Inc.、Neurosense Therapeutics Ltd.较为活跃，换手率分别为150.25%、58.25%、18.23%，振幅较大的相关个股有Immuneering Corporation、Neurosense Therapeutics Ltd.、Biomea Fusion, Inc.，振幅分别为29.20%、27.17%、24.33%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408012154209719879a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408012154209719879a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVNC","BK4585","LU0053671581.USD","BK4588","BK4007","LENZ"],"gpt_icon":0},{"id":"2456154102","title":"Revance Therapeutics, Inc.盘中异动 大幅拉升5.14%报3.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456154102","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456154102?lang=zh_cn&edition=full","pubTime":"2024-08-01 00:10","pubTimestamp":1722442257,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日00时10分，Revance Therapeutics, Inc.股票出现波动，股价快速上涨5.14%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Renovaro Inc.、Applied Therapeutics, Inc.、Zevra Therapeutics, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.、Bionomics Ltd Ads Each Rep 180 Ord Shs较为活跃，换手率分别为154.31%、147.53%、140.90%，振幅较大的相关个股有Renovaro Inc.、Alpha Tau Medical Ltd C/Wts 、Salarius Pharmaceuticals, Inc.，振幅分别为79.10%、44.12%、40.61%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801001057aefc7de3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801001057aefc7de3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVNC","BK4007","BK4139","LU0053671581.USD","LENZ","BK4588","BK4585"],"gpt_icon":0},{"id":"2454040148","title":"Revance Therapeutics, Inc.盘中异动 大幅拉升5.09%报4.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454040148","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454040148?lang=zh_cn&edition=full","pubTime":"2024-07-26 00:57","pubTimestamp":1721926639,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日00时57分，Revance Therapeutics, Inc.股票出现异动，股价大幅上涨5.09%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Exicure, Inc.较为活跃，换手率分别为4663.52%、556.67%、279.61%，振幅较大的相关个股有Psyence Biomedical Ltd.、Exicure, Inc.、Salarius Pharmaceuticals, Inc.，振幅分别为152.48%、132.26%、98.60%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726005719aefb7b0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726005719aefb7b0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","RVNC","BK4007","LENZ","BK4588","BK4585","BK4139"],"gpt_icon":0},{"id":"2454821038","title":"免疫学药物销售强劲，艾伯维上调年度盈利预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2454821038","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454821038?lang=zh_cn&edition=full","pubTime":"2024-07-25 19:36","pubTimestamp":1721907396,"startTime":"0","endTime":"0","summary":"    路透7月25日 - 艾伯维  周四上调了年度利润预期，因为包括Humira在内的主要免疫学药物的强劲销售帮助其第二季度业绩超过了华尔街的预期。艾伯维在2月 ，预计今年Humira在美国的销售额将下降36%。该制药公司及其投资者一直关注较新的免疫学药物Skyrizi和Rinvoq的销售，以抵消Humira需求的减少。第二季度，该抗癌药的全球销售额下降了 8%，降至 8.33 亿美元，但仍超过了 7.89 亿美元的预期。调整后，艾伯维每股收益为 2.65 美元，超出预期 8 美分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","IE00B19Z9P08.USD","ABBV","IE0005OL40V9.USD","LU0109391861.USD","LU0158827948.USD","IE00B7SZLL34.SGD","LU1699723380.USD","IE00BFSS7M15.SGD","CI","LU0029864427.USD","LU0265550946.USD","CVS","LU0868494617.USD","IE00BBT3K403.USD","IE00BLSP4239.USD","LU0545039389.USD","LU1244550577.SGD","RVNC","LU1261432733.SGD","EOLS","IE00BZ1G4Q59.USD","IE00B19Z3B42.SGD","IE00B1BXHZ80.USD","LU0187121727.USD","LU0094547139.USD","LU0211326839.USD","LU0266013472.USD","LU1496350502.SGD","IE00BSNM7G36.USD","LU1037948897.HKD","IE00BJT1NW94.SGD","LU1941712348.USD","LU0417517546.SGD","LU1066051498.USD","LU1934455194.USD","LU0965508806.USD","IE00B1XK9C88.USD","IE00BWXC8680.SGD","IE00B19Z3581.USD","LU0256863902.USD","IE00B894F039.SGD","LU1093756168.USD","LU1037948541.HKD","IE00BFSS8Q28.SGD","LU1934455277.USD","LU0058720904.USD","IE0002270589.USD","MRK"],"gpt_icon":1},{"id":"2453884134","title":"Revance Therapeutics, Inc.盘中异动 急速跳水5.27%报4.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453884134","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453884134?lang=zh_cn&edition=full","pubTime":"2024-07-24 23:13","pubTimestamp":1721834018,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日23时13分，Revance Therapeutics, Inc.股票出现波动，股价急速下挫5.27%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Dermata Therapeutics, Inc.、Pieris Pharmaceuticals, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Dermata Therapeutics, Inc.、Azitra Inc、Gri Bio, Inc.较为活跃，换手率分别为7712.48%、1205.66%、626.90%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Sangamo Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts ，振幅分别为191.54%、99.60%、72.79%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724231338aefb4250&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724231338aefb4250&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","LU0053671581.USD","RVNC","BK4585","BK4139","BK4588"],"gpt_icon":0},{"id":"2453058620","title":"Revance Therapeutics, Inc.盘中异动 急速拉升5.11%报4.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453058620","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453058620?lang=zh_cn&edition=full","pubTime":"2024-07-23 21:54","pubTimestamp":1721742845,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日21时54分，Revance Therapeutics, Inc.股票出现波动，股价大幅上涨5.11%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Azitra Inc、Adial Pharmaceuticals, Inc、Salarius Pharmaceuticals, Inc.涨幅较大，Azitra Inc、Adial Pharmaceuticals, Inc、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为2812.12%、1688.47%、124.39%，振幅较大的相关个股有Azitra Inc、Adial Pharmaceuticals, Inc、Salarius Pharmaceuticals, Inc.，振幅分别为365.43%、95.28%、43.40%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723215405941f9a65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723215405941f9a65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4588","BK4007","LU0053671581.USD","RVNC","BK4585"],"gpt_icon":0},{"id":"2453168717","title":"Revance Therapeutics, Inc.盘中异动 下午盘大幅上涨5.09%报3.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453168717","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453168717?lang=zh_cn&edition=full","pubTime":"2024-07-23 01:39","pubTimestamp":1721669979,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日01时39分，Revance Therapeutics, Inc.股票出现异动，股价急速上涨5.09%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Apollomics Inc C/Wts 01/04/2028 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、Mei Pharma, Inc.较为活跃，换手率分别为121.91%、113.16%、69.43%，振幅较大的相关个股有Anew Medical Inc C/Wts 21/06/2029 、Mei Pharma, Inc.、木薯科学，振幅分别为44.07%、37.06%、33.41%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407230139399681eeff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407230139399681eeff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4139","LENZ","RVNC","LU0053671581.USD","BK4007"],"gpt_icon":0},{"id":"2452431103","title":"Revance Therapeutics, Inc.盘中异动 大幅下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452431103","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452431103?lang=zh_cn&edition=full","pubTime":"2024-07-19 00:11","pubTimestamp":1721319077,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日00时11分，Revance Therapeutics, Inc.股票出现异动，股价急速跳水5.05%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.18%。其相关个股中，Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Onconetix, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为2300.31%、2274.30%、1196.93%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719001117af9300cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719001117af9300cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","LU0053671581.USD","RVNC","BK4007","BK4585","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.revance.com","stockEarnings":[{"period":"1week","weight":1.2339},{"period":"1month","weight":0.5506},{"period":"3month","weight":1.1821},{"period":"6month","weight":0.1853},{"period":"1year","weight":-0.6486},{"period":"ytd","weight":-0.2503}],"compareEarnings":[{"period":"1week","weight":0.0423},{"period":"1month","weight":-0.0209},{"period":"3month","weight":0.0446},{"period":"6month","weight":0.1072},{"period":"1year","weight":0.258},{"period":"ytd","weight":0.1636}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Revance Therapeutics, Inc.于1999年8月10日成立于特拉华公司，当时名为Essentia Biosystems公司。公司是一家处于专业临床阶段的生物制药公司，专注于开发、制造和商业化用以美容和治疗的异常型肉毒杆菌毒素产品。肉毒杆菌毒素是一种良好的蛋白，目前广泛应用于美容和治疗适应症，在美国和其他国家是一个数十亿美元的市场。目前批准和商用的肉毒杆菌毒素都是注入型的。RT001, 公司的主要候选产品，是a型肉毒毒素局部配方,相对于现有注射肉毒杆菌毒素市场产品，被认为有显著的优势。公司的第二个候选产品RT002，是一种新型注射肉毒杆菌毒素类型的配方，其设计更有针对性，与其他肉毒杆菌毒素注射产品相比，更持久。这些候选产品，结合了公司的净化肉毒杆菌毒素和专有肽输送系统。公司对其两个候选产品，在全球拥有发行权利。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.017146},{"month":2,"riseRate":0.6,"avgChangeRate":0.034292},{"month":3,"riseRate":0.363636,"avgChangeRate":0.011213},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.023839},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.009304},{"month":6,"riseRate":0.636364,"avgChangeRate":0.025437},{"month":7,"riseRate":0.272727,"avgChangeRate":0.019423},{"month":8,"riseRate":0.454545,"avgChangeRate":0.053639},{"month":9,"riseRate":0.5,"avgChangeRate":0.012838},{"month":10,"riseRate":0.4,"avgChangeRate":-0.075574},{"month":11,"riseRate":0.3,"avgChangeRate":-0.003095},{"month":12,"riseRate":0.6,"avgChangeRate":0.084189}],"exchange":"NASDAQ","name":"Revance Therapeutics Inc","nameEN":"Revance Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Revance Therapeutics Inc(RVNC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Revance Therapeutics Inc(RVNC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Revance Therapeutics Inc,RVNC,Revance Therapeutics Inc股票,Revance Therapeutics Inc股票老虎,Revance Therapeutics Inc股票老虎国际,Revance Therapeutics Inc行情,Revance Therapeutics Inc股票行情,Revance Therapeutics Inc股价,Revance Therapeutics Inc股市,Revance Therapeutics Inc股票价格,Revance Therapeutics Inc股票交易,Revance Therapeutics Inc股票购买,Revance Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Revance Therapeutics Inc(RVNC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Revance Therapeutics Inc(RVNC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况